Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis.
暂无分享,去创建一个
R. Sato | S. Tohma | M. Kawashima | H. Matsui | J. Suzuki | Shunsuke Akashi | A. Tamura | H. Nagai | Nobuharu Ohshima | M. Suzukawa | O. Narumoto | Akira Yamane | Ryo Sekiguchi | K. Takeda
[1] Hsin-Yun Sun,et al. CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status. , 2019, The Journal of infection.
[2] P. Kerndt,et al. Multicenter study of QuantiFERON®-TB Gold Plus in patients with active tuberculosis. , 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[3] N. Klein,et al. Seasonal variation in the performance of QuantiFERON-TB Gold In-Tube assays used for the diagnosis of tuberculosis infection. , 2018, Tuberculosis.
[4] M. Landini,et al. Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis , 2017, Journal of Clinical Microbiology.
[5] H. Sugiyama,et al. Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[6] G. Ippolito,et al. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis. , 2017, Tuberculosis.
[7] H. Ayles,et al. The sensitivity of the QuantiFERON®-TB Gold Plus assay in Zambian adults with active tuberculosis , 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[8] G. Ippolito,et al. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus. , 2016, The Journal of infection.
[9] T. Ottenhoff,et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis , 2016, European Respiratory Journal.
[10] Peter J Dodd,et al. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling , 2016, PLoS medicine.
[11] H. Hoffmann,et al. Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the presious test version QuantiFERON-TB Gold IT , 2016, Pneumologie.
[12] S. Ishikawa,et al. Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan , 2016, Scientific Reports.
[13] P. Rancoita,et al. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening , 2016, European Respiratory Journal.
[14] Delia Goletti,et al. Tuberculosis Biomarkers: From Diagnosis to Protection , 2016, Infectious disease reports.
[15] P. Rancoita,et al. First independent evaluation of QuantiFERON-TB Plus performance , 2016, European Respiratory Journal.
[16] Ross J. Harris,et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries , 2015, European Respiratory Journal.
[17] Francesco Castelli,et al. Towards tuberculosis elimination: an action framework for low-incidence countries , 2015, European Respiratory Journal.
[18] A. Sanduzzi,et al. Performance of the Tuberculin Skin Test and Interferon-γ Release Assays: An Update on the Accuracy, Cutoff Stratification, and New Potential Immune-based Approaches , 2014, The Journal of Rheumatology. Supplement.
[19] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[20] Reuben Granich,et al. HIV infection-associated tuberculosis: the epidemiology and the response. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] Y. Obase,et al. Comparison of T-Cell Interferon-γ Release Assays for Mycobacterium tuberculosis-Specific Antigens in Patients with Active and Latent Tuberculosis , 2010, Lung.
[22] J. Flynn,et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies , 2009, Nature Reviews Microbiology.
[23] T. Mori,et al. Waning of the specific interferon-gamma response after years of tuberculosis infection. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] H. Bax,et al. A multicentre verification study of the QuantiFERON®-TB Gold Plus assay. , 2018, Tuberculosis.